Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Cantel Medical (CMD) Stock Price

News headlines about Cantel Medical (NYSE:CMD) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cantel Medical earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned news articles about the company an impact score of 46.7411269072172 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Shares of Cantel Medical (NYSE:CMD) opened at $110.18 on Friday. Cantel Medical has a 52-week low of $69.21 and a 52-week high of $110.74. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.48 and a current ratio of 2.44. The company has a market capitalization of $4,610.00, a PE ratio of 60.87 and a beta of 1.25.

The firm also recently announced a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be given a dividend of $0.085 per share. This is a positive change from Cantel Medical’s previous Semi-Annual dividend of $0.07. The ex-dividend date is Tuesday, January 16th. This represents a dividend yield of 0.17%. Cantel Medical’s dividend payout ratio is presently 7.73%.

In related news, EVP Eric W. Nodiff sold 2,868 shares of the company’s stock in a transaction dated Friday, October 20th. The stock was sold at an average price of $97.55, for a total transaction of $279,773.40. Following the sale, the executive vice president now owns 39,102 shares in the company, valued at approximately $3,814,400.10. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 12.30% of the stock is owned by corporate insiders.

WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Cantel Medical (CMD) Stock Price” was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.themarketsdaily.com/2018/01/13/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-cantel-medical-cmd-stock-price.html.

About Cantel Medical

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Insider Buying and Selling by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply